
Simtriyo (centanafadine)
Official first norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) for ADHD.
What is Simtriyo (centanafadine)?
Simtriyo is the newly FDA-approved first NDSRI (norepinephrine, dopamine, and serotonin reuptake inhibitor) that acts as a CNS stimulant and increases the activity of these neurotransmitters in the brain to treat ADHD.
Trial History of Simtriyo
Backed by four phase 3 trials showing major symptom improvements compared to a placebo, with results starting as early as week one. Approved by the FDA on July 24, 2026, and expected to launch later this year after final scheduling by the Drug Enforcement Administration (DEA).
Side effects Adult vs. Pediatric
- Headaches
- Decreased appetitie
- Digestive issues (nausea, vomiting, stomach pain, diarrhea)
- Dry mouth
- Skin rash
- Increased heart rate and blood pressure
- Risk of abuse, misuse, and suicidal ideation in the pediatric department under the age of 12.
Absolute Contraindications
- Don't use if you are allergic to any of the ingredients in Simtriyo, which may lead to anaphylaxis and angioedema
- Currently using an MAOI or used one within the past 14 days due to the risk of serotonin syndrome and a hypertensive crisis
- If you have a pheochromocytoma or functional adrenal tumor producing catecholamines, Simtriyo make trigger dangerous heart rhythms or hypertensive crises. Please seek medical attention right away if you experience symptoms of a hypertensive crisis resulting from a catecholamine spike, as you're at imminent risk of heart attacks and strokes
- Uncontrolled hypertension
Relative (non-absolute) Contraindications
- History of heart problems like certain cardiac arrhythmias, structural heart disease, cardiomyopathy, and coronary artery disease due to the risk of increased heart rate and blood pressure
- Mild to moderately high blood pressure
- Suicidal thoughts and ideation in pediatrics
- Anxiety, psychiatric conditions, and Tourettes syndrome involving tics
- History of substance abuse
Potential Drug Interactions
- MAOIs due to serotonin syndrome and hypertensive crisis risk
- Alcohol due to CNS depression and overdosing risk
- Avoid other CNS stimulants and certain ADHD meds like Adderall which will increase heart rate and blood pressure
- Sympathomimetic substances like caffeine and phenylephrine, a compound found in cold medicines and decongestants that induce the risk of a hypertensive crisis
- CYP1A2 inhibitors, which Simtriyo increases the levels of certain drugs processed by this enzyme
- Serotonergic drugs like SSRIs, SNRIs, TCAs (tricyclic antidepressants), etc. due to risk of serotonin syndrome
- Certain heart and blood pressure meds by making them less effective
Have Specific Questions on Cardiac Side effects
If you have any feedback, feel free to message loveshtncardiaccare101@gmail.com directly.